---

---

symbols : GSK    crawled time : 15:00   

save search

---

Peptide Therapeutics Market Projected to Reach $57.97 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-19 (Crawled : 15:00) - prnewswire.com
NVO | $122.71 -0.03% 0.17% 5M |

Health Technology

| 0.0% | O: -0.75% H: 0.0% C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 0.0% | O: -0.56% H: 0.0% C: 0.0%
LLY | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 0.0% | O: -0.21% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 0.0% | O: -0.15% H: 0.0% C: 0.0%
report reach therapeutics market

---

Antacids Market Projected to Reach $10.18 billion by 2030 - Exclusive Report by 360iResearch
Published: 2024-04-05 (Crawled : 15:00) - prnewswire.com
RBGPF | $51.61 6.46% 4.7K |

Consumer Non-Durables

| -4.52% | O: 2.8% H: 0.0% C: -4.35%
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -3.35% | O: -100.0% H: NaN% C: Infinity%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -3.54% | O: -1.77% H: 0.0% C: -1.81%
RBGLY | $10.35 -2.05% 990K |

Manufacturing

| -5.52% | O: -0.84% H: 0.09% C: -0.09%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -3.08% | O: -0.66% H: 1.63% C: 1.48%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -6.35% | O: -3.44% H: 0.0% C: 0.0%
report reach market

---

Global Sports Drink Market to Surpass Valuation of $32.89 Billion by 2030, with North America Dominating the Market as Demand for Sports Drinks with Natural Ingredients Increases, States Kings Research
Published: 2024-02-08 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -3.02% | O: 0.82% H: 0.0% C: 0.0%
TAP | $64.23 0.55% 0.0% 1.4M |

Consumer Non-Durables

| 6.38% | O: 0.0% H: 0.97% C: 0.89%
HRL | $34.74 1.05% 0.0% 2.3M |

Consumer Non-Durables

| 14.5% | O: -0.44% H: 0.61% C: -0.44%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -5.76% | O: -0.48% H: 0.16% C: 0.0%
america natural research global market

---

RNA- Based Therapeutic Market worth $29.41 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
Published: 2023-12-05 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 9.78% | O: -2.6% H: 1.1% C: -1.18%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -1.28% | O: 0.27% H: 0.12% C: 0.12%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 8.11% | O: -1.01% H: 0.39% C: 0.19%
SLN | $22.75 3.32% 3.21% 310K |

Health Technology

| 56.46% | O: 1.16% H: 5.02% C: 0.79%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -2.73% | O: -0.5% H: 0.0% C: 0.0%
IONS | $40.64 -0.42% -0.42% 850K |

Health Technology

| -20.7% | O: -0.72% H: 0.0% C: -2.13%
BIIB | $194.39 2.03% 1.99% 1.6M |

Health Technology

| -16.19% | O: -0.37% H: 0.21% C: -1.05%
ARWR | $22.33 -1.24% -1.25% 960K |

Health Technology

| -5.05% | O: -1.48% H: 0.67% C: -4.6%
report market

---

Global Sustained Release Excipients Markets, 2017-2022, 2022-2027F, 2032F: Escalating Demand for Advanced Drug Formulations, Fueled by Higher Prevalence of Chronic and Acute Diseases
Published: 2023-09-29 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 10.65% | O: -0.03% H: 0.0% C: -1.26%
AZNCF | $138.24 -4.19% 800 |

Health Technology

| -0.62% | O: 0.66% H: 0.0% C: -1.46%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -9.04% | O: 1.18% H: 0.06% C: -1.62%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 8.97% | O: 0.52% H: 0.37% C: -0.77%
AZN | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 1.25% | O: 2.02% H: 0.0% C: -1.54%
drug global

---

Innovations Redefine Treatment: Antispasmodic Drugs Industry to Reach $17.68 Billion by 2027
Published: 2023-07-26 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 14.45% | O: 1.5% H: 0.64% C: 0.64%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -14.33% | O: 0.26% H: 0.49% C: 0.39%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 10.92% | O: 0.14% H: 0.64% C: 0.34%
reach

---

USD 306.2 Billion Growth in Active Pharmaceutical Ingredients Market Size - Industry Analysis, Market Trends, Market Growth, Opportunities
Published: 2023-05-19 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 12.22% | O: -1.67% H: 1.53% C: 0.28%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 12.47% | O: -0.14% H: 1.45% C: 1.28%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 15.14% | O: 0.29% H: 1.35% C: 0.87%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -15.61% | O: 1.54% H: 0.0% C: 0.0%
active growth market

---

Zentalis to present positive clinical data in ovarian cancer combining azenosertib and chemotherapy, including at the 2023 ASCO Annual Meeting
Published: 2023-04-26 (Crawled : 15:00) - biospace.com/
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 6.15% | O: -4.57% H: 0.22% C: -1.98%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 7.29% | O: -0.03% H: 0.3% C: -2.63%
ZNTL | $12.97 3.43% 3.32% 1M |

Health Technology

| -41.67% | O: -0.23% H: 0.18% C: -1.43%
asco positive cancer meeting

---

ViiV Healthcare to present first head-to-head data for long-acting HIV treatment Cabenuva against daily oral Biktarvy at CROI 2023
Published: 2023-02-14 (Crawled : 15:00) - biospace.com/
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 14.77% | O: 0.74% H: 2.37% C: 1.92%
PFE A | $26.0 2.4% -0.15% 38M |

Health Technology

| -42.21% | O: 0.23% H: 0.25% C: -0.84%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 9.3% | O: -0.33% H: 0.06% C: -0.14%
treatment hiv biktarvy

---

Global Active Pharmaceutical Ingredients (APIs) Market Report, 2022 & 2023-2027: Biotech APIs Used in Biologics are Increasingly Becoming the Top-Selling Drugs in the Market
Published: 2023-01-16 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| Email alert Add to watchlist
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| Email alert Add to watchlist
NVSEF | $93.6375 6.88% 82K |

Health Technology

| Email alert Add to watchlist
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| Email alert Add to watchlist
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| Email alert Add to watchlist
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| Email alert Add to watchlist
global active biotech market

---

Global Bronchitis Treatments (Acute, Chronic) Market Report 2022-2027 Featuring Leading Players - AstraZeneca, Bayer, Cipla, Sanofi and Pfizer
Published: 2022-12-30 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 16.83% | O: 1.13% H: 0.0% C: 0.0%
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -3.69% | O: 0.77% H: 0.0% C: -0.74%
AZNCF | $138.24 -4.19% 800 |

Health Technology

| 0.14% | O: 1.08% H: 0.0% C: -0.25%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 1.62% | O: -0.01% H: 0.08% C: -0.95%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 12.72% | O: -0.37% H: 0.89% C: 0.4%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -6.26% | O: -0.39% H: 0.0% C: 0.0%
AZN | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 0.24% | O: -0.46% H: 0.38% C: 0.01%
global report sanofi market

---

Gastrointestinal Drugs Market Research Report by Drug Category, Route of Administration, Disease Type, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
Published: 2022-12-23 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 12.85% | O: -3.13% H: 0.0% C: -0.23%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -14.72% | O: 0.13% H: 0.71% C: 0.65%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 12.15% | O: -0.14% H: 0.28% C: -0.11%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -5.35% | O: -0.23% H: 0.0% C: 0.0%
covid-19 drug research global disease report impact gastrointestinal market

---

Effervescent Tablet Market to record USD 4.55 Bn incremental growth; North America to occupy 31% market share -- Technavio
Published: 2022-10-24 (Crawled : 15:00) - prnewswire.com
RBGPF | $51.61 6.46% 4.7K |

Consumer Non-Durables

| -19.94% | O: 0.3% H: 5.47% C: 5.47%
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 29.82% | O: 2.76% H: 0.25% C: -1.56%
RBGLY | $10.35 -2.05% 990K |

Manufacturing

| -23.32% | O: 0.0% H: 1.04% C: 0.15%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 20.73% | O: 0.6% H: 0.84% C: 0.19%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 24.25% | O: -0.72% H: 1.17% C: 0.38%
america market

---

Alopecia Market to be Worth $14.2 Billion by 2028: Grand View Research, Inc.
Published: 2022-09-14 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 31.38% | O: -4.98% H: 7.63% C: 2.67%
VTRS | $11.25 1.17% 1.16% 4.7M |

Health Technology

| 17.18% | O: 0.32% H: 1.05% C: -0.95%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -10.15% | O: 0.75% H: 0.0% C: 0.0%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 25.2% | O: -0.6% H: 0.41% C: -0.76%
market

---

Global Nasal Drug Delivery Mode Market Report (2022 to 2028) - by Therapeutic Application, Dosage Form, Container Type, System Type, End-users, Distribution and Region
Published: 2022-09-05 (Crawled : 15:00) - prnewswire.com
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| Email alert Add to watchlist
BDX | $234.12 0.42% 0.0% 1.3M |

Health Technology

| Email alert Add to watchlist
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| Email alert Add to watchlist
GLAXF | $20.2 -14.18% 510 |

Health Technology

| Email alert Add to watchlist
drug global system report distribution market

---

Fallopian Tube Cancer Therapeutics Market Research Report by Technavio predicts USD 628.28 Mn growth | North America to have a significant share
Published: 2022-08-29 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 21.69% | O: 0.3% H: 0.0% C: -2.7%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 12.58% | O: 0.39% H: 0.05% C: -0.9%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 19.31% | O: -0.33% H: 0.45% C: 0.09%
BAX | $39.47 -0.45% 0.0% 2.8M |

Health Technology

| -30.56% | O: -0.65% H: 0.92% C: 0.33%
ABBV | News | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 21.13% | O: -0.11% H: 0.38% C: -0.36%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| 10.09% | O: -0.75% H: 0.92% C: 0.23%
america research tube report therapeutics cancer growth market

---

Global Human Reproductive Technology Products and Markets Analysis Report 2022: Data from 2020-2021, Estimates for 2022, and CAGR Projections through 2027
Published: 2022-08-26 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 25.23% | O: 2.29% H: 0.61% C: 0.61%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 17.4% | O: 0.15% H: 0.83% C: -1.75%
global report technology

---

USD 363.81 million in Nicotine Patch Market Size with 47% of the contribution from North America - 17,000+ Technavio Reports
Published: 2022-08-16 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| 19.99% | O: 0.98% H: 1.55% C: -0.38%
WMT | News | $59.53 0.46% 0.0% 14M |

Retail Trade

| -54.81% | O: 4.75% H: 1.46% C: 0.34%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| 9.02% | O: -0.54% H: 1.08% C: 1.06%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| 13.3% | O: 0.23% H: 1.46% C: 0.66%
america market

---

Sareum submits Clinical Trial Authorisation application to UK MHRA for development of TYK2/JAK1 inhibitor SDC-1801 and provides an Operational Update
Published: 2022-07-28 (Crawled : 15:00) - biospace.com/
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -5.92% | O: -1.01% H: 0.0% C: -2.13%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -9.05% | O: -1.54% H: 0.91% C: 0.14%
sdc-1801 application trial update

---

Electroceuticals Global Market Report 2022-2027: Focus on Non-Drug Therapies and Reducing Opioid Usage Creates Opportunities
Published: 2022-07-22 (Crawled : 15:00) - prnewswire.com
GLAXF | $20.2 -14.18% 510 |

Health Technology

| -3.53% | O: 2.77% H: 2.56% C: -0.09%
MDT | $79.48 0.37% -0.29% 6.7M |

Health Technology

| -12.39% | O: 0.32% H: 1.18% C: 0.19%
GSK | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -5.67% | O: -0.07% H: 1.14% C: 0.81%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -3.88% | O: 1.18% H: 0.0% C: -2.5%
LIVN | $52.31 -0.85% -0.86% 430K |

Health Technology

| -15.31% | O: 0.54% H: 0.96% C: -1.59%
global opioid report market

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | News | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---